GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Singapore O&G Ltd (SGX:1D8) » Definitions » Forward PE Ratio

Singapore O&G (SGX:1D8) Forward PE Ratio : 0.00 (As of Jun. 10, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Singapore O&G Forward PE Ratio?

Singapore O&G's Forward PE Ratio for today is 0.00.

Singapore O&G's PE Ratio without NRI for today is 15.56.

Singapore O&G's PE Ratio (TTM) for today is 15.56.


Singapore O&G Forward PE Ratio Historical Data

The historical data trend for Singapore O&G's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Singapore O&G Forward PE Ratio Chart

Singapore O&G Annual Data
Trend 2020-12
Forward PE Ratio
14.06

Singapore O&G Semi-Annual Data
Forward PE Ratio

Competitive Comparison of Singapore O&G's Forward PE Ratio

For the Medical Care Facilities subindustry, Singapore O&G's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Singapore O&G's Forward PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Singapore O&G's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Singapore O&G's Forward PE Ratio falls into.



Singapore O&G Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Singapore O&G  (SGX:1D8) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Singapore O&G Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Singapore O&G's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Singapore O&G (SGX:1D8) Business Description

Traded in Other Exchanges
N/A
Address
229 Mountbatten Road, No. 02-02 Mountbatten Square, Singapore, SGP, 398007
Singapore O&G Ltd is a Singapore based group of medical practioners dedicated to women's health and wellness in the obstetrics and gynaecology field. Its areas of specialisation are pregnancy care and delivery; the female reproductive system; gynaecological and breast cancer; skin and aesthetic treatments; and other ancillary medical services. The segments of the group are Obstetrics and Gynaecology, Cancer-related, Dermatology, Paediatrics and Corporate. It generates a majority of the revenue from the Obstetrics and Gynaecology Segment which relates to general obstetrics, labour and delivery, general gynaecology and surgery, female pelvic medicine, and urogynaecology and reconstructive surgery. All the operations of the organization are carried out in Singapore.

Singapore O&G (SGX:1D8) Headlines

No Headlines